Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Mentor, OH
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Ohio
mi
from
Mentor, OH
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Mission Hills, CA
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in California
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Great Neck, NY
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Great Neck, New York
mi
from
Great Neck, NY
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Houston, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Bologna,
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Bologna, Italy
mi
from
Bologna,
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Mesa, AZ
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Arizonia
mi
from
Mesa, AZ
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Missouri
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Asheville, NC
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in North Carolina
mi
from
Asheville, NC
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Mentor, OH
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Ohio
mi
from
Mentor, OH
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Chesapeake, VA
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Virginia
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Palm Harbor, FL
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Florida
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Mission Hills, CA
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Mission Hills, California
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Oxnard, CA
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Oxnard, California
mi
from
Oxnard, CA
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Great Neck, NY
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Great Neck, New York
mi
from
Great Neck, NY
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Greenville, SC
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Greenville, South Carolina
mi
from
Greenville, SC
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Houston, Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated:  12/31/1969
mi
from
Bologna,
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Bologna, Italy
mi
from
Bologna,
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Dothan, AL
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Tucson, AZ
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Jonesboro, AR
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Anaheim, CA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Downey, CA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Paramount, CA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Paramount, CA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
San Diego, CA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Council Bluffs, IA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Bardstown, KY
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bardstown, KY
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Nicholasville, KY
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nicholasville, KY
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Metairie, LA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Woburn, MA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Woburn, MA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Bridgeton, MO
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bridgeton, MO
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Kansas City, MO
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Omaha, NE
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Dayton, OH
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Fairfield, OH
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fairfield, OH
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Grants Pass, OR
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Grants Pass, OR
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Gresham, OR
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gresham, OR
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Erie, PA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Erie, PA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Hermitage, PA
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hermitage, PA
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Goodlettsville, TN
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Goodlettsville, TN
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Tullahoma, TN
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tullahoma, TN
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Layton, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Layton, UT
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Orem, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Roy, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roy, UT
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Salt Lake City, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
South Jordan, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
South Jordan, UT
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
Syracuse, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Syracuse, UT
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from
West Jordan, UT
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials